Novolog 100 unit/ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJG8M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,751
Award facts
- Contract value 100% obligated
- $23,750.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,750.60 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL), a rapid-acting insulin product used in diabetes management. The contract was awarded on January 8, 2026, with an ultimate completion date of January 9, 2026, and utilizes firm fixed-price pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at up to $999,999,999.00 and extends through December 2026, serving as a comprehensive pharmaceutical supply vehicle for military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical federal medical procurement vendor. The company's DLA IDC encompasses a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military treatment facilities and other federal healthcare systems. The competitively awarded delivery orders under this vehicle demonstrate the company's established capability to efficiently fulfill government requirements for essential pharmaceutical commodities, with individual task orders ranging from minimal values to over $45,000 depending on medical supply needs.
Quick answers
Who was awarded contract SPE2DR26FJG8M?
SPE2DR26FJG8M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FJG8M worth?
The government has obligated $23,751 on SPE2DR26FJG8M.
Is contract SPE2DR26FJG8M an order under another contract?
Yes. SPE2DR26FJG8M is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJG8M competed?
The extent of competition for SPE2DR26FJG8M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award